Clinical Trial Update: A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GSK3858279 for diabetic neuropathic pain was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• GSK3858279

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain | Phase 2 | Status: TERMINATED | Results posted: 2025-11-21